Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients

Clinical Cancer Research

Volumn 11, Issue 2 I, 2005, Pages 621-631

  Bérgamo, Nádia Aparecida ^a   Da Silva Veiga, Luciana Caricati ^a   Dos Reis, Patricia Pintor ^c   Nishimoto, Inês Nobuko ^b   Magrin, José ^b   Kowalski, Luiz Paulo ^b   Squire, Jeremy A ^c   Rogatto, Sílvia Regina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME 10; CHROMOSOME 12P; CHROMOSOME 15; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOSOMY; MONOSOMY 17; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; SQUAMOUS CELL CARCINOMA; Y CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CYTOGENETICS; DNA, NEOPLASM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MONOSOMY; NEOPLASM STAGING; PROGNOSIS; SPECTRAL KARYOTYPING; SURVIVAL RATE;

EID: 12244289921     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
3. Foulkes WD, Brunet J-S, Kowalski LP, Narod AS, Franco EL. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int J Cancer 1995;63:769-73.
4. Mitelman F, Johansson B, Mertens F, Mitelman Database of chromosome aberration in cancer. In: Mitelman F, Johansson B, Mertens F, editors. http://cgap.nci.nih.gov/Chromosomes/Mitelman. 2004.
5. Jin Y, Higashi K, Mandahal N, et al. Frequent rearrangement of chromosomal bands, 1p22 and 11q13 in squamous cell carcinomas of the head and neck. Genes Chromosomes Cancer 1990;2:198-204.
6. Jin Y, Mertens F, Mandahl N, et al. Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: influence of culture conditions on karyotypic patterns. Cancer Res 1993;53:2140-6.
7. Jin Y, Mertens F, Jin C, et al. Nonrandom chromosome abnormalities in short-term cultured primary squamous cell carcinomas of the head and neck. Cancer Res 1995;55:3204-10.
8. Jin C, Jin Y, Wennerberg J, et al. Clonal chromosome aberrations accumulate with age in upper aerodigestive tract mucosa. Mutat Res 1997;374:63-74.
9. Jin Y, Höglund M, Jin C, et al. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer 1998;22:312-20.
10. Jin C, Jin Y-S, Wennerberg J, Akervall J, Dictor M, Mertens F. Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. Cancer Genet Cytogenet 2002;132:85-96.
11. Rao PH, Sreekantaiah C, Schantz SP, Chaganti RSK. Cytogenetic analysis of 11 squamous cell carcinomas of the head and neck. Cancer Genet Cytogenet 1994;77:60-4.
12. Van Dyke DL, Worsham MJ, Benninger MS. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 1994;9:192-206.
13. Hermsen MAJA, Joenje H, Arwert F, et al. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer 1996;5:1-9.
14. Mertens F, Johansson B, Höglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997;57:2765-80.
15. Silva Veiga LC, Bérgamo NA, Reis PP, Kowalski LP, Rogatto SR. DNA gains at 8q23.2: a potential early marker in head and neck carcinomas. Cancer Genet Cytogenet 2003;146:110-5.
16. WHO. International classification of diseases for oncology. 2nd ed. Geneva: WHO; 1990.
17. AJCC, American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: J.B. Lippincott; 1998.
18. Scheres VMJC. Identification of two Robertsonian translocations with a Giemsa technique. Hum Genet 1972;15:253-6.
19. International System for Human Cytogenetic Nomenclature. Guidelines for cancer cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Mitelman F, editor. Basel: S. Karger; 1995.
20. Rogatto SR, Rainho CA, Zhang ZM, et al. Hemangioendothelioma of bone in a patient with a constitutional supernumerary marker. Cancer Genet Cytogenet 1999;110:23-7.
21. Dracopoli NC. Current protocols in human genetics [CD version]. New York: John Wiley & Sons, Inc.; 2000.
22. McDermid H, McTaggart KE, Riazi MA, et al. Long-range mapping and construction of a YAC contig within the cat eye syndrome critical region. Genome Res 1996;6:1149-59.
23. Schröck E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-7.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
25. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 2000;36:311-27.
26. Gollin SM. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 2001;23:238-53.
27. Knuutila S, Autio K, Aalto Y. Online access to CGH data of DNA sequence copy number changes. Am J Pathol 2000;157:689.
28. Struski S, Doco-Fenzy M, Cornillet-Lefebvre P. Compilation of published comparative genomic hybridization studies. Cancer Genet Cytogenet 2002;135:63-90.
29. Jin C, Jin Y, Wennerberg J, Dictor M, Mertens F. Nonrandom pattern of cytogenetic abnormalities in squamous cell carcinoma of the larynx. Genes Chromosomes Cancer 2000;28:66-76.
30. Reis PP, Poli-Frederico RC, dos Santos RM, Nishimoto IN, Kowalski LP, Rogatto SR. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. Med Sci Monit 2002;8:89-94.
31. Zaslav AL, Stamberg J, Steiberg BM, Lin YJ, Abramsom A. Cytogenetic analysis of head and neck carcinomas. Cancer Genet Cytogenet 1991;56:181-7.
32. Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND, Greenman J. Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridization. Br J Cancer 2003;89:864-9.
33. Bérgamo NA, Rogatto SR, Poli-Frederico RC, et al. Comparative genomic hybridization analysis detects frequent overrepresentation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas. Cancer Genet Cytogenet 2000;119:48-55.
34. Bockmühl U, Schwendel A, Dietel M, Petersen I. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinoma. Cancer Res 1996;56:5325-9.
35. Bockmühl U, Petersen S, Schmidt S, et al. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 1997;57:5213-6.
36. Bockmühl U, Wölf G, Schmidt S, et al. Genomic alterations associated with malignancy in head and neck cancer. Head Neck 1998;20:145-51.
37. Matsumura K, Iritani A, Enomoto S, et al. Defining a common region of DNA amplification at 22q11.2-12 in head neck squamous cell carcinomas by quantitative FISH analysis. Genes Chromosomes Cancer 2000;29:207-12.
38. Reis PP, Rogatto SR, Kowalski LP, et al. Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. Oncogene 2002;21:6480-7.
39. Beder LB, Gunduz M, Ouchida M, et al. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest 2003;83:99-105.
40. Shin DM, Lee JS, Lippman SM, et al. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:519-29.
41. Korver W, Guevara C, Chen Y, et al. The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the γ-tubulin complex. Int J Cancer 2003;104:283-8.
42. Llewellyn IE, Morris CM, Stanworth S, Heaton DC, Spearing RL. Trisomy 10 in Acute Leukemia. Cancer Genet Cytogenet 2000;118:148-50.
43. Suzuki A, Kimura Y, Ohyashiki K, et al. Trisomy 10 in acute myeloid leukemia. Cancer Genet Cytogenet 2000;120:141-3.
44. Weber RG, Scheer I, Born A, et al. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 1998;153:295-303.
45. Wolff E, Girod S, Liehr T, et al. Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridization. Oral Oncol 1998;34:186-90.
46. Tanner MM, Tirkkonem M, Kallioniemi A, et al. Amplification of region 20q13 in invasive beast cancer: prognostic implication. Clin Cancer Res 1995;1:1455-61.
47. Weber RG, Pietsch T, von Schweinitz D, Lichter P. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 2000;157:571-8.
48. Dodson MK, Hartmann LC, Cliby WA, et al. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res 1993;53:4456-60.
49. Wick W, Petersen I, Schmutzler RK, et al. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to metastatic stage in breast cancer. Oncogene 1996;12:973-8.
50. Balsara BR, Bell DW, Sonoda G, et al. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Res 1999;59:450-4.
51. Feenstra M, Veltkamp M, van Kuik J, et al. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 1999;54:235-45.
52. Wiktor A, Rybicki BA, Piao ZS, et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer 2000;27:11-6.
53. Logan JA, Seizinger BR, Atkins L, et al. Loss of the chromosome Y in meningiomas: a molecular genetic approach. Cancer Genet Cytogenet 1990;45:41-7.
54. Tricoli JV, Bracken RB. ZFY gene expression and retention in human prostate adenocarcinoma. Genes Chromosomes Cancer 1993;6:65-72.
55. Tricoli JV, Yao JL, D'Souza SA, Bracken RB. Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes Chromosomes Cancer 1993;8:28-33.
56. Skaletsky H, Kurodo-Kawaguchi T, Minsx PJ, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003;423:825-37.
57. Rozen S, Skaletsky H, Marszalek JD, et al. Abundant gene conversion between arms of palindromes in human and ape Y chromosomes. Nature 2003;423:873-6.
58. Huang Q, Yu GP, McCormick SA, et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 2002;34:224-33.